Tejara Capital LTD Teva Pharmaceutical Industries LTD Transaction History

Tejara Capital LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$12.78 - $17.4 $4.62 Million - $6.29 Million	-361,618 Reduced 46.35%	418,588 $6.8 Billion
Q1 2024 May 14, 2024	SELL	$10.67 - $14.43 $2.94 Million - $3.98 Million	-275,800 Reduced 26.12%	780,206 $11 Billion
Q4 2023 Feb 12, 2024	BUY	$8.12 - $10.63 $1.9 Million - $2.48 Million	233,511 Added 28.39%	1,056,006 $11 Billion
Q3 2023 Nov 13, 2023	BUY	$7.48 - $10.7 $2.2 Million - $3.14 Million	293,900 Added 55.6%	822,495 $8.39 Billion
Q2 2023 Aug 11, 2023	BUY	$7.2 - $9.47 $3.81 Million - $5.01 Million	528,595 New	528,595 $3.98 Billion

625

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $24.9B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Tejara Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Tejara Capital LTD with notifications on news.